![]() |
市場調查報告書
商品編碼
1828141
2025年全球雷射動脈粥狀硬化斑塊切除術設備市場報告Laser Atherectomy Devices Global Market Report 2025 |
近年來,雷射動脈粥狀硬化斑塊切除術設備市場呈現強勁成長勢頭,市場規模從2024年的12.2億美元成長至2025年的13億美元,複合年成長率達6.3%。這段時期的成長歸因於心血管疾病發生率的上升、複雜病變的治療、微創手術的普及、設備設計的改進、臨床證據的累積以及有效性的提升。
預計未來幾年,雷射動脈粥狀硬化斑塊切除術設備市場規模將強勁成長,2029年將達到18.2億美元,複合年成長率為8.8%。預測期內的成長歸因於對微創手術的需求、心血管疾病的增加、監管核准的不斷擴大、設備安全性和效率的提高以及醫生培訓項目的推進。預測期內的主要趨勢包括以患者為中心的護理、設備小型化和便攜性、個人化治療方法、影像技術的整合以及對安全性和有效性的關注。
雷射動脈粥狀硬化斑塊切除術儀是醫療設備。這類設備通常用於治療周邊動脈疾病(PAD) 和動脈粥狀硬化等疾病,這些疾病是由於斑塊中斑塊的積聚導致血管狹窄或阻塞。雷射動脈粥狀硬化斑塊切除術儀使用高能量雷射光束汽化斑塊,使清除阻塞物變得更容易。
雷射動脈粥狀硬化斑塊切除術設備主要分為兩種:電腦控制和非電腦控制。電腦控制是指使用電腦技術來管理和控制各種系統和流程。這類設備用於醫院、外科中心、門診手術中心和其他醫療機構的心血管、周邊血管和神經血管手術。
2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響,尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司(The Business Research Company)新報告系列的一部分,該系列提供雷射動脈粥樣動脈粥狀硬化斑塊切除術動脈粥狀硬化斑塊切除術設備市場統計數據,例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的雷射動脈粥狀硬化斑塊切除術粥樣硬化斑塊切除術設備細分市場、市場趨勢和商業機會,以及您在雷射動脈粥樣硬化動脈粥狀硬化斑塊切除術術設備行業取得成功所需的數據。這份雷射動脈粥狀動脈粥狀硬化斑塊切除術術設備市場研究報告對該行業的現狀和未來情況進行了詳細分析,為您提供所需的一切資訊的完整觀點。
未來五年8.8%的預測成長率,較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。美國可能會直接感受到這種影響,例如對來自荷蘭和台灣等主要地區的光纖雷射導管和生理食鹽水沖洗系統徵收關稅,這可能導致周邊動脈手術延遲,並增加血管介入治療的成本。此外,這種影響可能會透過互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,在更廣泛的層面上顯現。
動脈粥狀硬化盛行率的不斷上升預計將推動雷射粥狀動脈粥狀硬化斑塊切除術設備市場的成長。動脈粥狀硬化是一種以動脈中脂肪沉積物堆積為特徵的疾病,會導致動脈變窄和硬化。這會阻礙血液流向重要器官和組織,從而引發嚴重的健康併發症,如心臟病、中風和周邊動脈疾病。雷射粥樣動脈粥狀硬化斑塊切除術術設備透過雷射汽化斑塊,然後透過導管將其從體內移除來治療動脈硬化。例如,根據英國舉措提高醫療品質的哨兵中風國家審計計劃,2023 年 3 月,2022/23 年有 91,162 例中風住院治療,比 2021/22 年的 92,054 例略有下降。因此,動脈粥狀硬化盛行率的不斷上升是推動雷射粥狀動脈粥狀硬化斑塊切除術設備市場成長的關鍵因素。
由於心血管疾病 (CVD) 盛行率的上升,雷射動脈粥狀硬化斑塊切除術設備市場預計也將成長。 CVD 包括影響心臟和血管、影響循環系統的疾病。心血管疾病的激增導致需要治療動脈阻塞和動脈粥狀硬化斑塊的患者數量增加,對雷射動脈粥狀動脈粥狀硬化斑塊切除術設備的需求量很高。 2022 年 8 月,美國心臟學會預測,糖尿病、血脂異常症、高血壓和肥胖症將會增加,導致 2025 年至 2060 年間美國所有四種心血管危險因子都會增加。報告強調,預計中風、心臟衰竭、缺血性心臟疾病和心臟病發作將顯著增加。因此,心血管疾病的增加正在推動雷射動脈粥動脈粥狀硬化斑塊切除術設備市場的發展。
為了滿足更廣泛的客戶群、增加銷售額和提高整體收益,雷射動脈粥狀硬化斑塊切除術設備市場的主要企業正在積極創新,以創造先進的產品,包括動脈粥狀硬化斑塊切除系統。動脈粥狀硬化斑塊切除術斑塊切除醫療設備就是這種趨勢的一個例子,它是專門設計用於去除血管中動脈粥狀硬化斑塊的醫療設備。例如,2022 年 8 月,美國醫療設備公司 AngioDynamics Inc. 宣布其 Auryon 動脈粥狀硬化斑塊切除系統已獲得美國食品藥物管理局(FDA) 的擴大標籤批准。 Auryon 動脈粥狀硬化動脈粥狀硬化斑塊切除術系統因其有效治療各種類型鼠蹊部病變的能力而聞名,包括膝上 (ATK)、膝下 (BTK) 和支架內血管再阻塞(ISR)。該系統配備最尖端科技,可為動脈阻塞提供強力的治療。它是一種先進的雷射旋切系統,可有效治療任何類型、長度和位置的病變,同時最大限度地減少對血管壁的影響。
雷射動脈動脈粥狀硬化斑塊切除術設備市場的主要企業也專注於開發先進的解決方案,例如動脈粥狀硬化斑塊切除平台,以滿足更大基本客群的需求,推動更多銷售,並增加收益。動脈粥狀硬化斑塊動脈粥狀硬化斑塊切除術平台是一個綜合系統或一套工具,旨在治療動脈斑塊狀硬化,這是一種以動脈斑塊堆積為特徵的疾病。例如,2023 年 10 月,美國醫療設備公司 CardioFlow Inc. 宣布 FDA 批准其 FreedomFlow 眼眶動脈粥狀動脈粥狀硬化斑塊切除術周邊平台。 FreedomFlow 平台採用現代作用機制,專門用於清除下肢動脈的斑塊阻塞。此導管的獨特設計利用角動量物理學,並結合了五個鑽石塗層球體,形成螺旋形狀,確保在推進和縮回過程中同時與血管壁接觸。此外,鑽石塗層尖端有助於驅動軸順利穿過狹窄的閉塞處。這種創新方法為醫生提供了一種高效、有效且適應性強的治療手段,用於治療各種血管直徑的複雜周邊動脈疾病(PAD),從踝部 2 毫米到髖部 8 毫米。此平台功能多樣,只需一台裝置即可處理同一血管內的多條動脈和多處阻塞。
2023年4月,美國醫療設備製造商雅培實驗室(Abbott Laboratories)收購了心血管系統公司(Cardiovascular Systems, Inc.),收購金額未揭露。此策略措施將整合心血管系統公司(CSI)先進的動脈粥狀硬化斑塊動脈粥狀硬化斑塊切除術系統,增強雅培治療血管疾病的能力。該系統旨在為血管成形術和支架置入置入術準備血管,並最終恢復血流。此次收購符合雅培在血管產品組合中更廣泛的投資策略,並增強了雅培為周邊動脈疾病和冠狀動脈疾病患者提供全面護理的能力。心血管系統公司是美國動脈粥狀動脈粥狀硬化斑塊切除術設備製造商,目前隸屬於雅培旗下。
雷射動脈粥狀硬化斑塊切除術設備市場的主要企業包括波士頓科學公司、Terumo Corporation、Medtronic公司、Avinger 公司、心血管系統公司、荷蘭皇家飛利浦公司、AngioDynamics 公司、碧迪公司、Eximo Medical 有限公司、康德樂公司、B. Braun SE、CR Bard 公司、雅培實驗室、Biotrond SEubampy Ktra、Vakex、Gtraak、Hakak 實驗室、BioVOak Fexakex、Hakakex、Gtraak、Hakak) 科公司、Volcano 公司、Atrium Medical 公司、拜耳公司、Biosensors 國際Group Limited、庫克醫療公司、Cordis 公司、Covidien 公司、美敦力血管公司、Shockwave Medical 有限公司、Acotec Scientific Holdings 有限公司、Advanced Catheter Therapies 公司和 ArioMedica 公司和 ArioMedica 有限公司。
2024年,北美是雷射斑塊切除術設備市場最大的地區。根據全球雷射斑塊動脈粥狀硬化斑塊切除術術設備市場報告,預測期內亞太地區將成為成長最快的地區。此雷射斑塊動脈粥狀硬化斑塊切除術設備市場報告涵蓋亞太地區、西歐、東歐、北美、南美以及中東和非洲。
雷射動脈粥狀硬化斑塊切除術設備市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙
雷射動脈粥狀硬化斑塊切除術設備市場包括 Turbo Elite、Diamondback 360、Phoenix 斑塊切除系統、Jetstream 斑塊切除系統、HawkOne 系統和 Ocelot 系統的銷售。此市場的價值是指“出廠價”,即產品製造商或生產商向其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品製造商提供的任何相關服務。
A laser atherectomy device is a medical instrument designed to employ laser energy for breaking down and removing blockages from blood vessels. This device is commonly utilized in the treatment of conditions such as peripheral artery disease (PAD) or atherosclerosis, where plaque buildup in the arteries leads to narrowing or blockages. The laser atherectomy device operates by delivering a high-energy laser beam to the plaque, causing it to vaporize and facilitating the removal of the blockage.
The primary types of laser atherectomy devices include those with computer control and others. Computer control involves the utilization of computer technology to manage and control various systems and processes. These devices find applications in cardiovascular, peripheral vascular, and neurovascular procedures and are employed by hospitals and surgical centers, ambulatory care centers, and other medical facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The laser atherectomy devices market research report is one of a series of new reports from The Business Research Company that provides laser atherectomy devices market statistics, including laser atherectomy devices industry global market size, regional shares, competitors with a laser atherectomy devices market share, detailed laser atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the laser atherectomy devices industry. This laser atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The laser atherectomy devices market size has grown strongly in recent years. It will grow from $1.22 billion in 2024 to $1.3 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rise in cardiovascular diseases, treatment of complex lesions, minimally invasive procedures, improvements in device design, clinical evidence and efficacy.
The laser atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.82 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to demand for minimally invasive procedures, rise in cardiovascular conditions, expansion of regulatory approvals, advancements in device safety and efficiency, physician training programs. Major trends in the forecast period include patient-centric care, miniaturization and device portability, personalized treatment approaches, integration of imaging technologies, focus on safety and efficacy.
The forecast of 8.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on fiber-optic laser catheters and saline flushing systems, sourced from key regions such as the Netherlands and Taiwan, which could lead to postponed peripheral artery treatments and higher costs for vascular interventions.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
An increase in the prevalence of atherosclerosis is anticipated to drive the growth of the laser atherectomy devices market. Atherosclerosis is a medical condition characterized by the accumulation of fat within the arteries, leading to their narrowing and hardening. This can impede blood flow to essential organs and tissues, resulting in severe health complications such as heart disease, stroke, and peripheral artery disease. Laser atherectomy devices are employed in the treatment of atherosclerosis by utilizing a laser to vaporize the plaque, which is subsequently removed from the body via a catheter. For example, in March 2023, the Sentinel Stroke National Audit Programme, a UK-based initiative focused on healthcare quality improvement, reported that there were 91,162 patients hospitalized for stroke in 2022/23, a slight decrease from 92,054 in 2021/22. Thus, the rising prevalence of atherosclerosis is a key factor driving the growth of the laser atherectomy devices market.
The laser atherectomy devices market is also anticipated to witness growth due to the rising incidence of cardiovascular diseases (CVD). CVD encompasses diseases affecting the heart or blood vessels, impacting the circulatory system. The surge in cardiovascular diseases leads to an increased number of patients requiring treatment for arterial occlusions and atherosclerotic plaque, thereby creating a higher demand for laser atherectomy devices. In August 2022, the American College of Cardiology projected an increase in all four cardiovascular risk factors between 2025 and 2060 in the United States, with diabetes, dyslipidemia, hypertension, and obesity on the rise. The report highlighted substantial projected increases in stroke, heart failure, ischemic heart disease, and heart attack rates. Therefore, the growth of cardiovascular diseases propels the laser atherectomy devices market.
Leading companies in the laser atherectomy devices market are actively innovating to create advanced products, including atherectomy systems, to cater to broader customer bases, drive increased sales, and boost overall revenue. An atherectomy system, a medical device specifically crafted for the removal of atherosclerotic plaque from blood vessels, exemplifies this trend. For instance, in August 2022, AngioDynamics Inc., a US-based medical device company, revealed that the Auryon Atherectomy System had received Expanded Indications clearance from the United States Food and Drug Administration (FDA). The notable feature of the Auryon Atherectomy System lies in its capacity to effectively address various infrainguinal lesion types, spanning above-the-knee (ATK), below-the-knee (BTK), and in-stent restenosis (ISR). Employing cutting-edge technology, this system delivers powerful treatment for arterial occlusions. Significantly, it distinguishes itself as a pioneering laser atherectomy system capable of efficiently treating lesions of any type, length, and location with minimal impact on vessel walls.
Prominent companies in the laser atherectomy devices market are also investing efforts in developing advanced solutions, such as atherectomy platforms, to meet the demands of larger customer bases, drive more sales, and enhance revenue. An atherectomy platform constitutes a comprehensive system or set of tools designed for treating atherosclerosis-a medical condition characterized by plaque buildup in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced FDA clearance for the FreedomFlow, an orbital atherectomy peripheral platform. The distinctive feature of the FreedomFlow platform lies in its contemporary mechanism of action tailored to clear plaque blockages in leg arteries. Its exclusive catheter-based design leverages angular momentum physics, creating a spiral geometry that ensures simultaneous contact with the vessel wall during both advancement and retraction through the incorporation of five diamond-coated spheres. Additionally, a diamond-coated tip facilitates the smooth passage of the driveshaft through narrow blockages. This innovative approach provides physicians with an exceptionally efficient, effective, and adaptable means of treating complex Peripheral Artery Disease (PAD) across a broad spectrum of vessel diameters, ranging from 2 mm in the ankle to 8 mm in the hip. The platform offers greater versatility in addressing multiple arteries and multiple blockages within the same vessel, all achieved with a single device.
In April 2023, Abbott Laboratories, a US-based medical device company, completed the acquisition of Cardiovascular Systems, Inc. for an undisclosed amount. This strategic move enhances Abbott's capabilities to address vascular disease by incorporating CSI's leading atherectomy system designed to prepare vessels for angioplasty or stenting, ultimately restoring blood flow. The acquisition aligns with Abbott's broader investment strategy in its vascular portfolio, fortifying its ability to deliver comprehensive care for patients dealing with peripheral and coronary artery disease. Cardiovascular Systems Inc., a US-based manufacturer of atherectomy devices, now operates as part of Abbott's portfolio.
Major companies operating in the laser atherectomy devices market include Boston Scientific Corporation, Terumo Corporation, Medtronic plc, Avinger Inc., Cardiovascular Systems Inc., Koninklijke Philips N.V., AngioDynamics Inc., Becton, Dickinson and Company, Eximo Medical Ltd., Cardinal Health, B. Braun SE, C. R. Bard Inc., Abbott Laboratories, Biotronik SE & Co. KG, Rex Medical, Spectranetics Corporation, Straub Medical AG, Vascular Solutions Inc., Volcano Corporation, Atrium Medical Corporation, Bayer AG, Biosensors International Group Ltd., Cook Medical LLC, Cordis Corporation, Covidien plc, Medtronic Vascular, Shockwave Medical Inc., Acotec Scientific Holdings Ltd., Advanced Catheter Therapies Inc., ArioMedica Ltd.
North America was the largest region in the laser arthectomy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period. The regions covered in the laser atherectomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the laser atherectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The laser atherectomy devices market consists of sales of turbo elite, diamondback 360, phoenix atherectomy system, jetstream atherectomy system, hawkone system, and ocelot system. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Laser Atherectomy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on laser atherectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for laser atherectomy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The laser atherectomy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.